Welcome to Newomics -
Newomics Inc., an early stage biotechnology company in the San Francisco Bay Area, commercializes innovative (
) and integrative (
) platforms and solutions for personalized healthcare.
Mass spectrometry is the enabling technology for proteomics. To fully realize the enormous potential of lab-on-a-chip in proteomics.
Multinozzle Emitter Array Chip
Integrated Platforms for Precision Medicine
Biomarker discovery and validation
Microfluidic chip design and manufacture
News & Events
Newomics and Thermo Fisher Scientific will present the collaborative work on Newomics next-generation multinozzle emitters for nano-, micro-electrospray mass spectrometry at 62nd ASMS Conference (June 15-19, 2014).
Newomics is developing Assay-Specific Devices (
GenomeWeb.com news article
Newomics publishes a new solution for diabetes monitoring in
J. of Proteome Research
© 2014 Newomics, Inc. All Rights Reserved.